A carregar...
The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
BACKGROUND AND AIMS: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) are effective against classical EGFR mutations in lung cancer. However, their effectiveness and the prognosis of lung cancer patients with complex EGFR mutations are not well delineated. Therefore, we aimed...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7418472/ https://ncbi.nlm.nih.gov/pubmed/32843903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920946156 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|